Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 79 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots FDA launches AI tool for its employees Pilots Omada Health debuts on Nasdaq at $19 per share Pilots University of New South Wales trials brain game for chronic pain treatment LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Addiction care startup Eleanor Health scores $50M Pilots - April 8, 2022 0 Digital MSK startup IncludeHealth scores $11M and more digital health fundings Pilots - February 16, 2023 0 Talkspace launches behavioral health consortium with specialty care providers Pilots - April 30, 2024 0 Cerebral announces third round of layoffs in less than a year Pilots - March 1, 2023 0 Sprinter scores $55M for home healthcare offering Pilots - May 16, 2025 0 POPULAR CATEGORIESPilots2367Applications834Testing285Collaborations15GitHub3